Agarase mutant with improved acid resistance and thermal stability and application of agarase mutant in preparation of porphyra oligosaccharide

By performing multi-point mutation of agarase, especially His85 mutation to Tyr and Ser143 mutation to Glu, the problem of insufficient thermal stability and acid resistance of agarase is solved, and effective under high temperature and low pH conditions is achieved Degradation has improved the industrial production capacity of seaweed oligosaccharides.

CN119020201APending Publication Date: 2024-11-26JIANGSU COASTAL DEV & INVESTMENT CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411077828.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The poor thermal stability and insufficient acid resistance of agarase limit their use in industrial applications, especially in high temperature and low pH conditions, which is difficult to effectively degrade seaweed polysaccharides, and limits the industrial production of seaweed oligosaccharides.

Method used

By performing multi-point mutations on wild-type agarase, especially His85 mutation to Tyr and Ser143 mutation to Glu, agarase mutants HSYE and QSLE with significantly enhanced acid resistance and thermal stability, expanding their effective pH Range and temperature range allow it to remain active under wider conditions.

Benefits of technology

It significantly improves the acid resistance and thermal stability of agarase, enables it to be used in combination with commercial enzyme preparations, enhances the prospects in industrial applications, realizes the large-scale preparation of seaweed oligosaccharides, and reduces production costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020201A_ABST
    Figure CN119020201A_ABST
Patent Text Reader

Abstract

The invention provides an agarase mutant with improved acid resistance and thermal stability and application of the agarase mutant in preparation of porphyra oligosaccharide. The agarase mutant is obtained by mutating wild agarase derived from Pseudoalteromonas sp.Q34, and amino acid sequences of the agarase mutant HSYE and the agarase mutant QSLE are respectively shown as SEQ ID NO.2 and SEQ ID NO.3. Compared with the wild agarase, the agarase mutant has the advantages that the temperature stability and the acid resistance are obviously improved, and the half-life period at 50 DEG C is prolonged by 10 times; the half-life period when the pH value is 4.0 is prolonged by 5 times. The agarase mutant provided by the invention can improve the degradation rate of porphyra polysaccharide and the yield of galactooligosacharide, and has a better industrial application prospect. The application of the agarase in the seaweed processing industry is promoted, active products such as porphyra oligosaccharides are developed, commercialization of the agarase can be promoted, upgrading of the porphyra processing industry is promoted, and the method has important significance in achieving high value of marine resources and promoting upgrading of the porphyra industrial structure.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of gene engineering technology and enzyme engineering, and specifically relates to an agarase mutant with improved acid resistance and thermal stability and application thereof in preparing laver oligosaccharides. Background Art

[0002] Porphyra polysaccharides are mainly composed of galactose, mannose and glucose. In recent years, porphyra oligosaccharides have attracted increasing attention for their biological activities such as lowering blood lipids, anti-oxidation and anticoagulation, and their application potential in functional foods is huge. The methods for degrading porphyra polysaccharides to prepare porphyra oligosaccharides include physical, chemical and enzymatic hydrolysis, each with its own unique advantages and disadvantages. Enzymatic hydrolysis is considered to be a sustainable and most commercially promising method. The enzymes that degrade porphyra polysaccharides are mainly agarase, cellulose and amylase. At present, the effective action temperature of commercially produced cellulose and amylase is 30℃~80℃, the best is 45℃~60℃, the effective pH is 3.0~5.5, and the optimum pH is 4.5~5.5. However, agarase generally has poor thermal stability, and is rapidly inactivated when the temperature exceeds 40℃. Its effective pH is 6.5~7.5, which makes it difficult to use with commercial enzyme preparations, greatly limiting the development of its industrial application. However, laver polysaccharides often need higher temperatures or low pH to be dissolved, which is obviously inconsistent with the acid resistance and thermal stability of agarase, and its performance needs to be improved through molecular modification. The current modification of agarase is mainly to improve the catalytic efficiency and thermal stability of the enzyme. For example, "A kind of agarase mutant and its encoding gene and application" (CN114934033B), "A kind of agarase mutant with improved thermal stability by site-directed mutagenesis" (CN109207459B), "A kind of β-agarase mutant and its application of immobilized enzyme" (CN 116004580 A) respectively improve the temperature resistance of agarase by mutating glutamic acid (E) at position 122 to tryptophan (W), aspartic acid at position 602 to glycine (D602G), arginine at position 66 to cysteine, lysine at position 211 to cysteine, and asparagine at position 452 to cysteine. However, there are few studies and reports on improving the acid resistance of agarase through mutation. Summary of the invention

[0003] In response to the actual industrial production needs, the present invention provides a mutant agarase with improved acid resistance and thermal stability and its application in the preparation of laver oligosaccharides. Pseudoalteromonas sp.The agarase GH50 of Q34 was subjected to multiple mutations to obtain an agarase mutant with significantly enhanced acid resistance and thermal stability, which can effectively degrade laver polysaccharides and meet the needs of industrial production of laver oligosaccharides. It is helpful to promote the application of agarase in the seaweed processing industry and develop active products such as laver oligosaccharides, which can not only promote the commercialization of agarase, but also promote the upgrading of the laver processing industry, which is of great significance to realizing the high value of marine resources and promoting the upgrading of the laver industry structure.

[0004] In order to achieve the above-mentioned invention object, the present invention adopts the following technical solutions: The present invention provides a pseudoalteromonas Q34, which is classified and named as pseudoalteromonas Pseudoalteromonas sp. , which is deposited in China Center for Type Culture Collection with the deposit number CCTCC NO: M20241182.

[0005] The present invention provides an agarase mutant HSYE with improved acid resistance and thermal stability. The amino acid sequence of the mutant HSYE is shown in SEQ ID NO.2; the mutant HSYE is obtained by mutation of His at position 85 to Tyr and mutation of Ser at position 143 to Glu in the agarase shown in the amino acid sequence of SEQ ID NO.1.

[0006] The present invention provides an agarase mutant QSLE with improved acid resistance and thermal stability. The amino acid sequence of the mutant QSLE is shown in SEQ ID NO.3; the mutant QSLE is obtained by mutating the 14th Gln of the agarase shown in the amino acid sequence of SEQ ID NO.1 to Leu, and the 143rd Ser to Glu.

[0007] In one embodiment of the present invention, the nucleotide sequence of the agarase parent enzyme is shown in SEQ ID NO.4.

[0008] The invention also provides a gene encoding an agarase mutant.

[0009] In one embodiment of the present invention, when the agarase mutant is HSYE, the nucleotide sequence of its encoding gene is shown as SEQ ID NO.5.

[0010] In one embodiment of the present invention, when the agarase mutant is QSLE, the nucleotide sequence of its encoding gene is shown as SEQ ID NO.6.

[0011] The invention also provides a recombinant vector carrying the gene.

[0012] In one embodiment of the present invention, the recombinant vector uses pHT43 as an expression vector.

[0013] The present invention also provides the mutant, or a recombinant cell containing the gene, or containing the recombinant vector.

[0014] In one embodiment of the present invention, the recombinant cell uses a prokaryotic cell or a eukaryotic cell as an expression host.

[0015] In one embodiment of the present invention, the expression host is Bacillus subtilis.

[0016] The present invention also provides a recombinant Bacillus subtilis, wherein the Bacillus subtilis expresses the agarase mutant.

[0017] The present invention also provides a method for preparing an agarase mutant, comprising the following steps: (1) Construction of agarase mutant recombinant cells: Transform the recombinant vector containing the agarase mutants HSYE and QSLE into Bacillus subtilis to obtain agarase mutant recombinant cells; (2) Expression and purification of agarase mutants: The agarase mutant recombinant cells are cultured, induced to express the recombinant protein, and the agarase mutants are isolated and purified.

[0018] The present invention also provides the use of agarase mutant, agarase mutant encoding gene, recombinant vector, recombinant cell or agarase mutant prepared by the above preparation method in degrading laver polysaccharide to prepare laver oligosaccharide.

[0019] Furthermore, the steps of the application are: (1) The laver raw material is processed to obtain a powder with a particle size greater than 20 mesh; (2) adding 20 to 35 times the weight of water of the raw material to the powder in step (1), heating to boiling, maintaining for 10 minutes, and extracting to obtain a polysaccharide solution; (3) adding ethanol solution to the polysaccharide solution in step (2), allowing to stand at room temperature, and collecting the precipitate by centrifugation; (4) preparing the precipitate in step (3) into a solution, adding the composite enzyme preparation for enzymolysis, and obtaining an enzymolysis solution; (5) The enzymatic hydrolyzate in step (4) is graded and dried to obtain laver oligosaccharides.

[0020] Furthermore, in the step (4), the amount of agarase mutant added to the composite enzyme preparation is 4 to 40 U / g of the precipitate weight, the amount of cellulose added is 0.2 to 4% of the precipitate weight, and the amount of amylase added is 0.5 to 10% of the precipitate weight.

[0021] Furthermore, the enzymatic hydrolysis conditions in step (4) are a temperature of 30°C to 50°C, a pH of 4.0 to 6.0, and a time of 5 to 12 h.

[0022] Preferably, the enzymatic hydrolysis conditions in step (4) are temperature 40°C, pH 5.0, and time 8 h.

[0023] Furthermore, the ultrafiltration coarse fractionation conditions in step (5) are as follows: the molecular weight cutoff of the ultrafiltration membrane is 3000 kDa and 200 kDa, and the segment between 200 and 3000 kDa is taken as the target laver oligosaccharide.

[0024] Compared with the prior art, the advantages and beneficial effects of the present invention are as follows: (1) The present invention is to treat wild-type Pseudoalteromonas sp. After multiple mutations were performed on the agarase of Q34 (whose amino acid sequence is shown in SEQ ID NO.1) and the wild agarase and mutants were characterized, it was proved that the agarase mutant with significantly enhanced acid resistance and thermal stability was obtained, which can be effectively used in combination with commercial enzyme preparations, greatly improving the application prospects of agarase in industry.

[0025] (2) The effective pH range of the agarase mutants HSYE and QSLE provided by the present invention is reduced from 6.0 to 8.0 of the wild type to 4.0 to 7.5; the optimum pH is reduced from 7.5 of the wild type to 5.0; the half-life is increased by 3 times at pH 4.0; and the half-life is increased by 10 times at pH 5.0. It can be seen that the acid stability of the agarase mutants of the present invention is significantly improved.

[0026] (3) The thermal stability of the agarase mutants HSYE and QSLE provided by the present invention is significantly improved; the half-life at 40°C is increased by 4 times; the half-life at 45°C is increased by 9 times; and the half-life at 50°C is increased by 10 times. It can be seen that the thermal stability of the agarase mutants of the present invention is significantly improved.

[0027] (4) The present invention uses agarase mutants and commercial enzyme preparations to degrade laver polysaccharides, and then performs ultrafiltration classification to specifically prepare laver oligosaccharides containing sulfate groups from laver, and the molecular weight of the product is less than 1000 Da, and the degree of polymerization is 2-6. The present invention provides for the first time a large-scale preparation process for laver oligosaccharides from laver, and the process is simple and efficient, laying a foundation for the development and application of laver oligosaccharides.

[0028] (5) The agarase mutant provided by the present invention has significantly improved acid resistance and heat resistance, and can catalyze the degradation of laver polysaccharides at a higher temperature to prepare laver oligosaccharides. Low pH and high temperature are conducive to the dissolution of laver polysaccharides to maintain a sol state and avoid coagulation, thereby increasing the degradation rate of laver polysaccharides, reducing production costs, and meeting the needs of industrial production. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 This is a comparison of the optimal pH of wild-type agarase and mutants.

[0030] Figure 2 is the pH stability curve of wild-type agarase and mutants.

[0031] Figure 3 are the thermal inactivation curves of wild-type agarase and mutants.

[0032] Figure 4 This is the mass spectrum of laver oligosaccharides. DETAILED DESCRIPTION

[0033] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto.

[0034] Definitions of terms used in this invention Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

[0035] The amino acids in the various amino acid sequences appearing herein are represented by their well-known three-letter or single-letter abbreviations, such as the three-letter abbreviation Ser for serine and the single-letter abbreviation S. The nucleotides appearing in the various DNA fragments are represented by the standard single-letter identifiers routinely used in the art.

[0036] The term "nucleotide" means deoxyribonucleosides, ribonucleosides or ribonucleotides and polymers thereof. Unless specifically limited, the term encompasses nucleic acids containing known analogs of natural nucleotides that have similar binding properties to the reference nucleic acid and are metabolized in a manner similar to naturally occurring nucleotides.

[0037] The terms "mutation" and "mutant" refer to genetic, naturally occurring or introduced changes in nucleic acid or polypeptide sequences, and their meanings are the same as those generally known in the art.

[0038] The term "host cell" or "recombinant host cell" refers to a cell comprising a nucleotide or polypeptide or protein of the present invention. Exogenous nucleotides may be maintained as non-integrated vectors or may be integrated into the host genome.

[0039] The term "transformation" refers to the process by which a eukaryotic cell acquires new genetic markers as a result of the incorporation of foreign DNA.

[0040] The culture medium involved in the following examples is as follows: LB liquid medium: weigh 1g peptone, 0.5g yeast extract, and 1g NaCl. Dissolve in deionized water and make up to 100mL. Autoclave at 121℃ for 20min.

[0041] LB solid medium: Add 1.5% agar powder to LB liquid medium.

[0042] Agarase activity determination: The enzyme activity was determined using the 3,5-dinitrosalicylic acid method.

[0043] (1) Substrate preparation: Prepare pH 6.4 Na2HPO4-sodium citrate buffer and 0.2% (w / v) agar substrate; (2) Preheating: Place 2 mL of reaction substrate in a colorimetric tube and place in a 30°C water bath to keep warm; (3) Reaction: Add 0.05 mL of enzyme solution, shake to mix, react for 10 min, add 2.0 mL of DNS to terminate the reaction, boil in a boiling water bath for 5 min, and cool immediately; (4) Measurement: Measure the absorbance at 520 nm and calculate the enzyme activity.

[0044] Definition of enzyme activity unit: Under the conditions of 30℃ and pH 6.4, the amount of enzyme required to catalyze the substrate to produce 1μg D-galactose per minute is defined as one activity unit.

[0045] Steps for determining the optimal pH of an enzyme: (1) Reaction substrate preparation: Prepare Na2HPO4-sodium citrate buffer with different pH values, take an equal volume of buffer and prepare 0.2% (w / v) agar substrate; (2) Determine enzyme activity.

[0046] Enzyme pH stability determination steps: (1) Buffer preparation: Prepare Na2HPO4-sodium citrate buffer at pH 4.0 and pH 5.0; (2) Enzyme treatment: dilute the enzyme solution with the above buffer to the same enzyme activity concentration, store it at room temperature, and take samples at regular intervals to measure the enzyme activity; (3) Calculation of half-life: Record the enzyme activity at different treatment times, and calculate the treatment time at which the remaining enzyme activity is half of the initial enzyme activity as its half-life.

[0047] Enzyme thermal stability determination steps: (1) Enzyme treatment: Take equal amounts of enzyme solution and place them in a water bath at 40, 45, or 50°C. Samples are taken at regular intervals to measure enzyme activity. (2) Calculation of half-life: Record the enzyme activity at different treatment times, and calculate the treatment time at which the remaining enzyme activity is half of the initial enzyme activity as its half-life.

[0048] Example 1: Pseudoalteromonas Pseudoalteromonas sp. Screening of Q34 The present inventionPseudoalteromonas sp. Acquisition of Q34: Silt was collected from the intertidal zone of Jiaodong coast and added into a conical flask containing 100 mL of selective culture medium (0.5 g agar, 0.2 g peptone, 1.5 g K2HPO4, 0.5 g MgSO4, 10 g NaCl, 0.01 g CaCl2, 1000 mL water, natural pH). The culture was shaken at 30°C and 150 rpm for 72 h. After the culture medium was appropriately diluted with sterile saline, 0.1 mL was taken to spread on a primary screening separation culture medium (15 g agar, 0.2 g peptone, 1.5 g K2HPO4, 0.5 g MgSO4, 10 g NaCl, 0.01 g CaCl2, 1000 mL water, natural pH) plate. Inverted culture was carried out at 30℃ for 48 h, and a single colony with a depression on the plate was selected and inoculated onto a plate containing multiple screening separation medium (15 g agar, 1.5 g K2HPO4, 0.5 g MgSO4, 10 g NaCl, 0.01 g CaCl2, 1000 mL water, natural pH) using the three-zone streak method. Inverted culture was carried out at 30℃ for 48 h, and a single colony with a depression on the plate was selected and inoculated into a conical flask containing 40 mL fermentation medium (0.5 g agar, 1.5 g K2HPO4, 0.5 g MgSO4, 10 g NaCl, 0.01 g CaCl2, 1000 mL water, natural pH), and shake culture was carried out at 30℃ and 150 rpm for 24 h. After fermentation and enzyme activity measurement, a bacterium capable of producing agarase was obtained.

[0049] The present invention Pseudoalteromonas sp. Identification of Q34: The genome extraction, purification, cloning and sequencing were completed by Qingdao Ruibo Xingke Biotechnology Co., Ltd. The 16Sr DNA gene sequence sequencing results were compared with the Gen Bank database for homology to determine that it was a genus of Pseudomonas. After morphological and physiological and biochemical identification, its characteristics were: Gram-negative, no capsule, facultative anaerobic, oxidase positive, VP positive, can use glucose to produce acid without gas, and can reduce nitrate. The strain cell diameter is 0.4μm×1.1-1.5μm, and it was determined to be a Pseudomonas alternata, named Pseudoalteromonas sp. Q34.

[0050] Pseudoalteromonas Pseudoalteromonas sp. Q34 is used for strain preservation. Pseudoalteromonas sp. The depository of Q34 is China Center for Type Culture Collection (CCTCC); Address: Wuhan University, Wuhan, China; Deposit date: June 14, 2024; Pseudoalteromonas sp. The deposit number of Q34 is: CCTCC NO: M 20241182.

[0051] Example 2: Construction of agarase mutants (1) Construction of wild-type agarase recombinant vector: Extraction of Pseudoalteromonas in logarithmic growth phase Pseudoalteromonas sp. Q34 (deposit number: CCTCC NO. M 20241182), and the extracted genome sample was sequenced; according to the sequencing results and functional gene analysis, primers were designed to amplify the wild-type agarase gene, the amino acid sequence of agarase is shown in SEQ ID NO.1, and the nucleotide sequence of the agarase gene is shown in the sequence table SEQ.ID.NO.4; and they were connected with the plasmid to construct the recombinant vector pHT43-aga182.

[0052] aga182-F: AAAACATCAGCCGTAGGATCCGTGGCATCACAAGCAACAAACA (SEQ ID.NO.7) aga182-R: CATTAGGCGGGCTGCCCCGGGTTAATGATGATGATGATGATGTTTTTTAAATCGACGCTCGTAC (SEQ ID. NO. 8).

[0053] (2) Construction of agarase mutant recombinant vector: With the help of the design software Alphafold2, the three-dimensional structure of agarase was predicted, and the mutation points that affect the acid resistance and thermal stability of wild agarase were screened; through Gibbs free energy calculation, mutants with ΔΔG < 2.7 k J / mol were selected, and His 85 and Ser 143 Combination mutation to Tyr 85 and Glu 143 (HSYE), Gln 14 and Ser 143 Combination mutation to Leu 14 and Glu 143 (QSLE), Ala 628 and Ser 143 Combination mutation to Phe 628 and Glu 143 (SAEF), Ser 384 and Ser 143 Combination mutation to Leu 384 and Glu 143 (SSEL), His 85 Mutation to Tyr 85 (HY), respectively 143 Mutation to Glu 143 (SE), Gln 14 Mutation to Leu 14 (QE). Based on the strain codon preference, the mutation primers were designed as follows: Q13L-F: CCTGCTGCTGCTGTTATATGATGACCAACATACAGCTAA (SEQ ID NO.9) Q13L-R: ATAACAGCAGCAGCAGGGTTTTGCTGGTGTTT (SEQ ID NO.10) H84Y-F: AGGCCAATACTCAGTACAAATTTACTTAGATATCTCAGATATTG (SEQ ID NO.11) H84Y-R: GTACTGAGTATTGGCCTGGGTTTGCAAGTCCA (SEQ ID NO.12) S143E-F: CTTACGCGAGAATCCTGCAACATGGCAATCCG (SEQ ID NO.13) S143E-R: CAGGATTCTCGCGTAAGCCTGAGGTAAAGTTAAGC (SEQ ID NO.14) S384L-F: TTCTCTGAACCTAGAGCGTAAATATGGTCAAAA (SEQ ID NO.15) S384L-R:GCTCTAGGTTCAGAGAATAAAAGCTGTAAGTTTCACCATG (SEQ ID NO.16) A628F-F:ATTTTTACAAAGAAGGCATTAAACCTAAAAAA (SEQ ID NO.17) A628F-R: GCCTTCTTTGTAAAAATTAAAGCTTATCACATCAACATGCTT (SEQ ID NO.18) Using the wild-type agarase recombinant vector in step (1) as a template, the above primers were used to construct single point mutants HY, SE and QE, and then using the SE mutant recombinant plasmid as a template, combined mutants HSYE, QSLE, SAEF and SSEL were constructed.

[0054] The PCR reaction system is shown in Table 1.

[0055] Table 1 Mutation PCR reaction system

[0056] The PCR reaction conditions were as follows: pre-denaturation at 95°C for 3 min, denaturation at 95°C for 30 s, annealing at 55°C for 30 s, extension at 72°C for 10 min, for a total of 30 cycles, and final extension at 72°C for 5 min.

[0057] (3) Construction of agarase mutant recombinant cells: After the agarase mutant recombinant plasmids in step (2) were recovered and purified, they were transformed into Bacillus subtilis ( Bacillus subtilis ), spread the transformants on chloramphenicol (50 μg / mL) LB plates, culture at 37°C overnight, and after colonies grew, pick a single colony and transfer it to liquid LB medium containing chloramphenicol (50 μg / mL) and culture at 37°C, 160 rpm overnight.

[0058] Mutant engineered bacteria containing correct mutants were obtained respectively: B. subtilis pHT43-HSYE, B. subtilis pHT43-QSLE, B. subtilis pHT43-SAEF, B. subtilis pHT43-SSEL, B. subtilispHT43-HY, B. subtilis pHT43-SE, and B. subtilis pHT43-QE.

[0059] As a control: pHT43-aga182 was transformed into B. subtilis, and according to the above method, an engineered bacterium containing wild-type agarase was prepared: B. subtilis pHT43-aga182.

[0060] (4) Expression and purification of agarase mutants: The genetically engineered bacteria obtained in step (3) were streaked on LB plates containing chloramphenicol (50 μg / mL), cultured at 37°C for 12 h, and then single colonies were picked and inoculated into LB liquid culture medium containing chloramphenicol (50 μg / mL) for shake flask fermentation. The culture was carried out at 37°C and 200 rpm for 12 h to obtain seed solution.

[0061] 1 mL of seed solution was transferred to 100 mL of chloramphenicol (50 μg / mL) LB liquid medium for shake flask fermentation. Culture at 37°C until OD600 reached 0.6-0.8, then add IPTG at a final concentration of 0.5 mM, lower the temperature to 28°C, induce enzyme production, and collect the bacteria by centrifugation after 24 h of culture.

[0062] Add an appropriate amount (2-3 times the volume) of lysis buffer (50 mM Tris-HCl, 100 mM NaCl, pH 7.5) to the collected cells, and then ultrasonically disrupt them on ice. Centrifuge at 4°C, 8000 rpm for 10 min to collect the supernatant, and filter it with a 0.22 μm filter membrane. 2+ The mutant enzyme was purified by column affinity chromatography.

[0063] Pure enzyme solutions containing wild-type agarase and mutants HSYE, QSLE, SAEF, SSEL, HY, SE, and QE were prepared respectively.

[0064] (5) Determine the enzyme activity, optimal pH, pH stability, and thermal stability of the enzyme solution.

[0065] The results are as follows Figure 1 and Figure 2 As shown: the acid resistance of agarase mutants is significantly improved. After combined mutation, the effect of agarase in acidic environment is significantly improved, among which mutants HSYE and QSLE have the best effect, followed by mutants SAEF and SSEL. The effective pH range of mutants HSYE and QSLE is expanded from 6.0~8.0 of the wild type to 4.0~7.5, and the optimum pH is reduced from 7.5 of the wild type to 5.0; the effective pH range of mutants SAEF and SSEL is 5.0~7.0, and the optimum pH is reduced from 7.5 of the wild type to 5.5. In pH4.0 and pH5.0 environments, the stability of mutants HSYE and QSLE is significantly improved. In comparison, the effective pH range, optimum pH and acid resistance of point mutants HY, SE and QE are improved compared with the wild type, but lower than the combined mutants, and their acid resistance still cannot meet industrial needs. It can be seen that the acid resistance of the agarase mutants of the present invention is significantly improved.

[0066] The results are as follows Figure 3 As shown: the agarase mutant also has good temperature resistance. After the combined mutants HSYE and QSLE acted in an environment of 40°C for 300 minutes, their relative enzyme activity could still reach 80%. The corresponding residual enzyme activity tolerance time in an environment of 45°C was about 200 minutes, and the corresponding residual enzyme activity tolerance time in an environment of 50°C was about 100 minutes; while the corresponding residual enzyme activity tolerance time of the wild type in the above temperature environment was less than 60 minutes. The corresponding residual enzyme activity tolerance time of other mutants in the above temperature environment was improved relative to that of the wild type, but the effect was limited, less than 120 minutes. It can be seen that the temperature resistance of the agarase mutants of the present invention is significantly improved.

[0067] Table 2 Optimal pH and half-life results of wild-type agarase and its mutants

[0068] The test results of the optimum pH and half-life of wild-type agarase and its mutants are shown in Table 2: The acid resistance and temperature resistance of agarase mutants are significantly increased. Among them, the optimum pH of agarase mutants HSYE and QSLE is reduced from 6.4 of the wild type to 5.0; the half-life is increased by 3 times at pH 4.0; the half-life is increased by 10 times at pH 5.0; the half-life is increased by 4.8 times at 40°C; the half-life is increased by 5.2 times at 45°C; and the half-life is increased by 10 times at 50°C. The acid resistance and temperature resistance of mutants SAEF and SSEL are slightly lower than those of mutants HSYE and QSLE, and they also show good acid resistance and temperature resistance. Mutants HY, SE and QE show different acid resistance and thermal stability, but are only slightly better than the wild type. From the above, it can be seen that the acid resistance and thermal stability of agarase can be improved after mutation. The agarase mutants HSYE and QSLE provided by the present invention have excellent acid resistance and thermal stability, which are significantly better than those reported. The amino acid sequence of the agarase mutant HSYE is shown in SEQ ID NO.2, and the nucleotide sequence of the gene encoding the mutant HSYE is shown in SEQ ID NO.5; the amino acid sequence of the agarase mutant QSLE is shown in SEQ ID NO.3, and the nucleotide sequence of the gene encoding the agarase mutant QSLE is shown in SEQ ID NO.6.

[0069] The agarase mutants HSYE and QSLE provided by the present invention can be used in combination with commercial enzyme preparations at low pH and high temperature to meet industrial production requirements.

[0070] Example 3: Preparation of Porphyra Oligosaccharides by Different Enzymes Take 200 g of laver, dry, crush and sieve to obtain laver powder with a particle size greater than 20 mesh. Add 25 times the volume of water to the laver powder and heat to boiling, maintain for 10 min, centrifuge and take the supernatant to obtain a laver polysaccharide solution. Add 3 times the volume of ethanol solution to the laver polysaccharide solution, let it stand at room temperature, and centrifuge to collect the precipitate. Prepare the precipitate into a solution, without or with a certain amount of enzyme, control the temperature at 45℃, pH5.0, and time for 8 h to obtain an enzymatic solution; the enzymatic solution is first separated by an ultrafiltration membrane with a molecular weight cutoff of 3000 kDa, and the permeate is further concentrated by a nanofiltration membrane with a molecular weight cutoff of 200 kDa; the retentate of the 3000 kDa ultrafiltration membrane is further enzymolyzed and filtered repeatedly. The 200 kDa nanofiltration membrane is used to concentrate the solution and dry to obtain laver oligosaccharides. Calculate the extraction rate of laver oligosaccharides and detect the molecular weight of laver oligosaccharides.

[0071] On the basis of the above process, different enzymes were added, and the amount of each enzyme added was 1% of the weight of the precipitate. The effects of different enzymes on the preparation of laver oligosaccharides were analyzed: ①: No enzyme added; ②: wild-type agarase; ③: Agarase mutant mixed enzyme (HSYE and QSLE 50% each); ④: Agarase mutant enzyme mixture (50% each of HSYE and QSLE) + cellulase + amylase; ⑤: Cellulase + amylase; ⑥: Wild-type agarase + cellulase + amylase.

[0072] Table 3 Results of preparing porphyra oligosaccharides using different enzymes

[0073] The results are shown in Table 3: The addition of enzymes can significantly increase the yield of laver oligosaccharides. Moreover, only when agarase mutants are added can the yield of laver oligosaccharides be significantly increased. Agarase mutants + cellulase + amylase are selected as the composite enzyme preparation for the preparation of laver oligosaccharides, and the yield of laver oligosaccharides is the highest at this time.

[0074] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, it is still possible for a person skilled in the art to modify the technical solutions described in the aforementioned embodiments, or to replace some of the technical features therein by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions claimed to be protected by the present invention.

Claims

1. A Pseudoalteromonas Q34, It is characterized in that Pseudoalteromonas Pseudoalteromonas sp. , which is deposited in China Center for Type Culture Collection with the deposit number CCTCC NO: M20241182.

2. Agarase mutant HSYE with improved acid resistance and thermal stability, It is characterized in that The amino acid sequence of the mutant HSYE is shown in SEQ ID NO.2; the mutant HSYE is obtained by mutation of His at position 85 to Tyr and Ser at position 143 to Glu in the agarase shown in SEQ ID NO.

1.

3. Agarase mutant QSLE with improved acid resistance and thermal stability, It is characterized in that The amino acid sequence of the mutant QSLE is shown in SEQ ID NO.3; it is obtained by mutation of the 14th Gln to Leu and the 143rd Ser to Glu of agarase shown in SEQ ID NO.

1.

4. A gene encoding the agarase mutant HSYE according to claim 2 or the agarase mutant QSLE according to claim 3, It is characterized in that The nucleotide sequence of the gene encoding the agarase mutant HSYE is shown in SEQ ID NO.5, and the nucleotide sequence of the gene encoding the agarase mutant QSLE is shown in SEQ ID NO.

6.

5. A recombinant vector, It is characterized in that A gene encoding the agarase mutant according to claim 4.

6. A recombinant cell expressing the mutant according to claim 2 or 3, or carrying the encoding gene according to claim 4, or carrying the recombinant vector according to claim 5.

7. A composite enzyme preparation for degrading laver to prepare laver oligosaccharides, It is characterized in that The composite enzyme preparation contains agarase, cellulase and amylase, and the amino acid sequence of the agarase is shown in SEQ ID NO.1, or in SEQ ID NO.2, or in SEQ ID NO.

3.

8. Use of agarase or the complex enzyme preparation according to claim 7 in degrading laver to prepare laver oligosaccharides, It is characterized in that The amino acid sequence of the agarase is shown as SEQ ID NO.1, or as SEQ ID NO.2, or as SEQ ID NO.

3.

9. The use according to claim 8, It is characterized in that The steps of the application are: (1) processing laver raw materials to obtain laver powder; (2) adding 20 to 35 times the weight of water of the raw material to the laver powder, heating to boiling, and extracting to obtain a polysaccharide solution; (3) adding ethanol solution to the polysaccharide solution, allowing to stand at room temperature, and collecting the precipitate by centrifugation; (4) preparing the precipitate into a solution, adding a composite enzyme preparation for enzymolysis, and obtaining an enzymolysis solution; the amount of agarase added in the composite enzyme preparation is 4 to 40 U / g of the weight of the precipitate, the amount of cellulose added is 0.2 to 4% of the weight of the precipitate, and the amount of amylase added is 0.5 to 10% of the weight of the precipitate; (5) The enzymatic hydrolysate is graded and dried to obtain laver oligosaccharides.

10. The use according to claim 9, It is characterized in that The enzymatic hydrolysis conditions in step (4) are a temperature of 30°C to 50°C, a pH of 4.0 to 6.0, and a time of 5 to 12 h.